OtherHot Topics (Invitation Only)
The Australasian Radiopharmaceutical Trials Network (ARTnet) – Clinical Trials, Evidence and Opportunity.
Roslyn Francis, Dale Bailey, Michael S Hofman and Andrew Scott
Journal of Nuclear Medicine December 2020, jnumed.120.258152; DOI: https://doi.org/10.2967/jnumed.120.258152
Roslyn Francis
1 Sir Charles Gairdner Hospital;
Dale Bailey
2 Royal North Shore Hospital, Australia;
Michael S Hofman
3 Peter MacCallum Cancer Centre;
Andrew Scott
4 Austin Health, Australia
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
The Australasian Radiopharmaceutical Trials Network (ARTnet) – Clinical Trials, Evidence and Opportunity.
Roslyn Francis, Dale Bailey, Michael S Hofman, Andrew Scott
Journal of Nuclear Medicine Dec 2020, jnumed.120.258152; DOI: 10.2967/jnumed.120.258152
Jump to section
Related Articles
Cited By...
- 64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
- Perspectives on Cutting-Edge Clinical Trials: A Conversation Between Michael Hofman, Johannes Czernin, and Jeremie Calais